Partial T-cell activation and anergy induction by polyclonal antithymocyte globulin

Transplantation

Volumn 65, Issue 11, 1998, Pages 1481-1489

  Merion, Robert M ^a,b   Howell, Terese ^a   Bromberg, Jonathan S ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

POLYCLONAL ANTIBODY; THYMOCYTE ANTIBODY;

ANTIBODY PRODUCTION; ANTIGEN SPECIFICITY; ARTICLE; CELL MEDIATED CYTOTOXICITY; CELL PROLIFERATION; CLONAL ANERGY; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IMMUNOCOMPETENT CELL; PRIORITY JOURNAL; SUPERNATANT; T LYMPHOCYTE ACTIVATION; T LYMPHOCYTE SUBPOPULATION;

ANTILYMPHOCYTE SERUM; CELL DIVISION; CYTOTOXICITY, IMMUNOLOGIC; HUMANS; IMMUNE SYSTEM; IMMUNOSUPPRESSIVE AGENTS; INTERLEUKIN-2; INTERLEUKIN-4; LYMPHOCYTE ACTIVATION; RECEPTORS, CELL SURFACE; T-LYMPHOCYTES;

EID: 0032526008     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-199806150-00013     Document Type: Article

References (27)

1. Lance EM. The mechanism of action of anti-lymphocyte serum: studies of antibody eluate. J Exp Med 1969; 130: 49.
2. Zimmerman B, Baumal R, Gelfand EW. In vitro stimulation of human lymphocytes with heterologous anti-lymphocyte sera: evidence for a specific antigenic receptor mechanism. J Immunol 1974; 113: 413.
3. Thomas JM, Thomas F, Williams E, Scott J. In vitro studies on the mechanism of action of human antithymocyte globulin. Proc Clin Dial Transplant Forum 1977; 7: 141.
4. Young N, Speck B. Antithymocyte and antilymphocyte globulins: clinical trials and mechanism of action. Prog Clin Biol Res 1984; 148: 221.
5. Franco DJ, Monaco AP. Mechanism of action of antilymphocyte serum: effect on H-2 antibody formation, induction of allograft immunity, and tolerance to H-2 skin grafts. Surg Forum 1968; 19: 175.
6. Guttmann RD, Lindquist RR, Ockner SA, Merrill JP. Mechanism of long term survival of renal allografts after treatment with antilymphocyte antibody. Transplant Proc 1969; 1: 463.
7. Simpson M, Gozzo JJ. Studies on the mechanism of action of rabbit anti-mouse thymocyte serum. I. Induction of suppressor cells. Transplantation 1980; 30: 64.
8. Sheagren JN, Barth RF, Edelin JB, Malmgren RA. Mechanism of reticuloendothelial system blockade produced by antilymphocyte serum. J Immunol 1970; 105: 634.
9. Landegren U, Andersson J, Wigzell H. Mechanism of T lymphocyte activation by OKT3 antibodies: a general model for T cell induction. Eur J Immunol 1984; 14: 325.
10. Chatenoud L, Bach JF. Selective immunosuppression with anti-T cell monoclonal antibodies. Clin Nephrol 1992; 38 (suppl 1): S53.
11. Cosimi AB. Clinical development of Orthoclone OKT3. Transplant Proc 1987; 19 (suppl 1): 7.
12. Gimmi CD, Freeman GJ, Gribben JG, Gray G, Nadler LM. Human T-cell clonal anergy is induced by antigen presentation in the absence of B7 costimulation. Proc Natl Acad Sci USA 1993; 90: 6586.
13. Bourdage JS, Hamlin DM. Comparative polyclonal antithymocyte globulin and antilymphocyte/antilymphoblast globulin anti-CD antigen analysis by flow cytometry. Transplantation 1995; 59: 1194.
14. Condie RM, Sherburne CG. Identification of the lymphocyte epitopes with which clinically effective polyclonal ALG reacts. Transplant Proc 1989; 21: 973.
15. Bonnefoy-Bérard N, Vincent C, Revillard J-P. Antibodies against functional leukocyte surface molecules in polyclonal antilymphocyte and antithymocyte globulins. Transplantation 1991; 51: 669.
16. Abouna GM, Al-Abdullah IH, Kelly-Sullivan D, et al. Randomized clinical trial of antithymocyte globulin induction in renal transplantation comparing a fixed daily dose with dose adjustment according to T cell monitoring. Transplantation 1995; 59: 1564.
17. Kaden J, May G, Muller P, et al. Intraoperative high-dose anti-T-lymphocyte globulin bolus in addition to triple-drug therapy improves kidney graft survival. Transplant Proc 1995; 27: 1060.
18. Gascon P, Zounbos NC, Scala G, Djeu JY, Moore JG, Young NS. Lymphokine abnormalities in aplastic anemia: implications for the mechanism of action of antithymocyte globulin. Blood 1985; 65: 407.
19. Cantrell DA, Lucas SC, Ward S, Westwick J, Gullberg M. Phorbol esters regulate CD2- and CD3-mediated calcium responses in peripheral blood-derived human T cells. J Immunol 1989; 143: 3653.
20. Isakov N, Mally MI, Scholz W, Altman A. T-lymphocyte activation: the role of protein kinase C and bifurcating inositol phospholipid signal transduction pathway. Immunol Rev 1987; 95: 89.
21. Ward SG, Lampe D, Liu C, Potter BVL, Westwick J. Calcium release activity and metabolism of inositol 1,4,5-triphosphate in T cells. Eur J Biochem 1994; 222: 515.
22. Quill H, Schwartz RH. Stimulation of normal inducer T cell clones with antigen presented by purified Ia molecules in planar lipid membranes: specific induction of a long-lived state of proliferative nonresponsiveness. J Immunol 1987; 138: 3704.
23. Quill H. Anergy as a mechanism of peripheral T cell tolerance. J Immunol 1996; 156: 1325.
24. Mosmann TR, Coffman RL. TH1 and TH2 cells: different patterns of lymphokine secretion lead to different functional properties. Annu Rev Immunol 1989; 7: 145.
25. Sad S, Mosmann TR. Single IL-2-secreting precursor CD4 T cell can develop into either Th1 or Th2 cytokine secretion phenotype. J Immunol 1994; 153: 3514.
26. Dallman MJ, Shiho O, Page TH, Wood KJ, Morris PJ. Peripheral tolerance to alloantigen results from altered regulation of the interleukin 2 pathway. J Exp Med 1991; 173: 79.
27. Migita K, Eguchi K, Kawabe Y, Tsukada T, Ichinose Y, Nagataki S. Defective TCR-mediated signaling in anergic T cells. J Immunol 1995; 155: 5083.